Both in Pharmaceuticals
Ernexa Therapeutics vs Mustang Bio
Over the past year ERNA returned −89.2% and MBIO returned −69.5%; their daily moves had a correlation of 0.02.
ERNA −89.2% MBIO −69.5%Growth of $1, one year, split-adjusted
| Metric | ERNA | MBIO |
|---|---|---|
| Price | $3.16 | $0.4796 |
| Market cap | $3.7M | $3.6M |
| Today | −8.93% | −5.39% |
| 1 month | −30.9% | −10.8% |
| 6 months | −33.1% | −33.9% |
| Year to date | −89.5% | −51.1% |
| 1 year | −88.9% | −69.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $5.0M | $15.2M |
| Dividend yield | — | — |
| Volatility (60d) | 104.2% | 58.0% |
| Short % of float | 1.5% | 0.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).